These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 6313435

  • 21. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.
    Samuelsson B.
    Science; 1983 May 06; 220(4597):568-75. PubMed ID: 6301011
    [Abstract] [Full Text] [Related]

  • 22. Leukotrienes, allergy and inflammation.
    Nijkamp FP, Sitsen JM.
    Pharm Weekbl Sci; 1982 Dec 17; 4(6):165-71. PubMed ID: 6296757
    [Abstract] [Full Text] [Related]

  • 23. Leukotrienes: clinical significance.
    Goldyne ME.
    J Am Acad Dermatol; 1984 Apr 17; 10(4):659-68. PubMed ID: 6325514
    [Abstract] [Full Text] [Related]

  • 24. Role of leukotrienes and lipoxygenases in glomerular injury.
    Nassar GM, Badr KF.
    Miner Electrolyte Metab; 1995 Apr 17; 21(4-5):262-70. PubMed ID: 7565475
    [Abstract] [Full Text] [Related]

  • 25. Leukotrienes: their formation and role as inflammatory mediators.
    Ford-Hutchinson AW.
    Fed Proc; 1985 Jan 17; 44(1 Pt 1):25-9. PubMed ID: 2981730
    [Abstract] [Full Text] [Related]

  • 26. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G, Thomson DM, MacFarlane JK.
    Cancer Res; 1984 Mar 17; 44(3):1238-45. PubMed ID: 6420056
    [Abstract] [Full Text] [Related]

  • 27. Antiinflammatory drugs and the many mediators of inflammation.
    Vane JR.
    Int J Tissue React; 1987 Mar 17; 9(1):1-14. PubMed ID: 3110088
    [Abstract] [Full Text] [Related]

  • 28. Leukotrienes: positive signals for regulation of gamma-interferon production.
    Johnson HM, Torres BA.
    J Immunol; 1984 Jan 17; 132(1):413-6. PubMed ID: 6317747
    [Abstract] [Full Text] [Related]

  • 29. Receptor-specific mechanisms for the responses of human leukocytes to leukotrienes.
    Goetzl EJ, Sherman JW, Ratnoff WD, Harvey JP, Eriksson E, Seaman WE, Baud L, Koo CH.
    Ann N Y Acad Sci; 1988 Jan 17; 524():345-55. PubMed ID: 2837968
    [No Abstract] [Full Text] [Related]

  • 30. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M.
    Bull Acad Natl Med; 2006 Oct 17; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [Abstract] [Full Text] [Related]

  • 31. Leukotrienes and prostaglandins in the immune system.
    Parker CW.
    Adv Prostaglandin Thromboxane Leukot Res; 1986 Oct 17; 16():113-34. PubMed ID: 3028091
    [No Abstract] [Full Text] [Related]

  • 32. [The potential and significance of pharmacologic effects on leukotrienes and other lipoxygenase derivatives of arachidonic acid].
    Mayer M, Opavský J.
    Vnitr Lek; 1987 May 17; 33(5):502-7. PubMed ID: 3037786
    [No Abstract] [Full Text] [Related]

  • 33. [Prostaglandins, thromboxanes and leukotrienes. Their role in cardiovascular diseases, allergic reactions and inflammation].
    Maclouf J, Borgeat P, Grange MJ, Wautier JL, Caen JP.
    Presse Med; 1984 Jan 21; 13(2):91-6. PubMed ID: 6320156
    [Abstract] [Full Text] [Related]

  • 34. Understanding leukotrienes.
    Wardle N.
    Br J Hosp Med; 1986 Jun 21; 35(6):382, 384, 386-7. PubMed ID: 3013352
    [Abstract] [Full Text] [Related]

  • 35. Regulation of phytohemagglutinin-induced bovine lymphocyte blastogenesis by leukotrienes.
    Atluru D, Goodwin JS.
    Am J Vet Res; 1986 Sep 21; 47(9):1963-6. PubMed ID: 3021029
    [Abstract] [Full Text] [Related]

  • 36. IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells.
    Phillips MJ, Gold WM, Goetzl EJ.
    J Immunol; 1983 Aug 21; 131(2):906-10. PubMed ID: 6306109
    [Abstract] [Full Text] [Related]

  • 37. Biological actions of leukotrienes. State of the art lecture.
    Ford-Hutchinson A, Letts G.
    Hypertension; 1986 Jun 21; 8(6 Pt 2):II44-9. PubMed ID: 3013771
    [Abstract] [Full Text] [Related]

  • 38. Leukocytes and tissue injury: the use of eicosapentaenoic acid in the control of white cell activation.
    Moncada S, Salmon JA.
    Wien Klin Wochenschr; 1986 Feb 21; 98(4):104-6. PubMed ID: 3010576
    [Abstract] [Full Text] [Related]

  • 39. Leukotrienes and related compounds.
    Samuelsson B.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Feb 21; 15():1-9. PubMed ID: 3004127
    [No Abstract] [Full Text] [Related]

  • 40. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.
    Lewis RA, Austen KF.
    J Clin Invest; 1984 Apr 21; 73(4):889-97. PubMed ID: 6323538
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.